SomnoMed Statistics

Total Valuation

SomnoMed has a market cap or net worth of AUD 141.99 million. The enterprise value is 130.57 million.

Market Cap	141.99M
Enterprise Value	130.57M

Important Dates

The last earnings date was Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

SomnoMed has 218.44 million shares outstanding. The number of shares has increased by 19.96% in one year.

Current Share Class	218.44M
Shares Outstanding	218.44M
Shares Change (YoY)	+19.96%
Shares Change (QoQ)	+3.41%
Owned by Insiders (%)	8.36%
Owned by Institutions (%)	26.13%
Float	113.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	33.68
PS Ratio	1.20
PB Ratio	2.84
P/TBV Ratio	3.39
P/FCF Ratio	38.32
P/OCF Ratio	18.08
PEG Ratio	0.84

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.61, with an EV/FCF ratio of 35.24.

EV / Earnings	-51.04
EV / Sales	1.10
EV / EBITDA	20.61
EV / EBIT	120.57
EV / FCF	35.24

Financial Position

The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.13.

Current Ratio	1.76
Quick Ratio	1.34
Debt / Equity	0.13
Debt / EBITDA	1.04
Debt / FCF	1.78
Interest Coverage	2.21

Financial Efficiency

Return on equity (ROE) is -5.25% and return on invested capital (ROIC) is 2.80%.

Return on Equity (ROE)	-5.25%
Return on Assets (ROA)	0.87%
Return on Invested Capital (ROIC)	2.80%
Return on Capital Employed (ROCE)	1.97%
Weighted Average Cost of Capital (WACC)	9.26%
Revenue Per Employee	395,003
Profits Per Employee	-8,528
Employee Count	300
Asset Turnover	1.53
Inventory Turnover	6.65

Taxes

In the past 12 months, SomnoMed has paid 2.40 million in taxes.

Income Tax	2.40M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.04% in the last 52 weeks. The beta is 0.94, so SomnoMed's price volatility has been similar to the market average.

Beta (5Y)	0.94
52-Week Price Change	+13.04%
50-Day Moving Average	0.70
200-Day Moving Average	0.72
Relative Strength Index (RSI)	43.74
Average Volume (20 Days)	57,961

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SomnoMed had revenue of AUD 118.50 million and -2.56 million in losses. Loss per share was -0.01.

Revenue	118.50M
Gross Profit	70.87M
Operating Income	1.08M
Pretax Income	-161,863
Net Income	-2.56M
EBITDA	3.68M
EBIT	1.08M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 18.03 million in cash and 6.61 million in debt, giving a net cash position of 11.42 million or 0.05 per share.

Cash & Cash Equivalents	18.03M
Total Debt	6.61M
Net Cash	11.42M
Net Cash Per Share	0.05
Equity (Book Value)	50.04M
Book Value Per Share	0.23
Working Capital	18.91M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.85 million and capital expenditures -4.15 million, giving a free cash flow of 3.71 million.

Operating Cash Flow	7.85M
Capital Expenditures	-4.15M
Free Cash Flow	3.71M
FCF Per Share	0.02

Full Cash Flow Statement

Margins

Gross margin is 59.81%, with operating and profit margins of 0.91% and -2.16%.

Gross Margin	59.81%
Operating Margin	0.91%
Pretax Margin	-0.14%
Profit Margin	-2.16%
EBITDA Margin	3.10%
EBIT Margin	0.91%
FCF Margin	3.13%

Dividends & Yields

SomnoMed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.96%
Shareholder Yield	-19.96%
Earnings Yield	-1.80%
FCF Yield	2.61%

Stock Splits

The last stock split was on November 27, 2009. It was a reverse split with a ratio of 0.05.

Last Split Date	Nov 27, 2009
Split Type	Reverse
Split Ratio	0.05

Scores

SomnoMed has an Altman Z-Score of 3.36 and a Piotroski F-Score of 6.

Altman Z-Score	3.36
Piotroski F-Score	6